Who owns F/M Emerald Life Sciences Innovation ETF?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of LFSC from SEC Form 13F filings across 8 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 8 institutions disclosed 2.2M shares of F/M Emerald Life Sciences Innovation ETF worth $97.5M — about 82.9% of shares outstanding; the largest disclosed holder is EMERALD MUTUAL FUND ADVISERS TRUST. Source: SEC Form 13F filings, parsed by EvidInvest.
8
13F holders
$97.5M
value, 2026 filers
82.9%
of shares outstanding (2.2M sh)
3
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of LFSC's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | EMERALD MUTUAL FUND ADVISERS TRUST | 2.0M | $90.3M | 3.2% | 74.8% | 0.0% |
| 2 | SBE LLC DBA CEDAR COVE WEALTH PARTNERS | 70,126 | $3.2M | 1.5% | 2.6% | +0.2% |
| 3 | HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 57,742 | $2,611 | 0.3% | 2.2% | +16.1% |
| 4 | IHT Wealth Management, LLCNEW | 24,506 | $1.1M | 0.0% | 0.9% | new |
| 5 | Atria Investments, Inc | 24,506 | $1.1M | 0.0% | 0.9% | +9.7% |
| 6 | Old Port AdvisorsNEW | 22,613 | $1.0M | 0.2% | 0.8% | new |
| 7 | Tidal Investments LLC | 17,474 | $789,882 | 0.0% | 0.7% | -12.4% |
| 8 | FMR LLCNEW | 30 | $1,356 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.